Methylprednisolone Versus Dexamethasone in COVID-19: A Meta-Analysis of Nonrandomized Studies.

Beran, Azizullah; Ayesh, Hazem; Mhanna, Mohammed; Srour, Omar; Musallam, Rami; Sayeh, Wasef; Khokher, Waleed; Altorok, Nehaya; Noori, Zaid; Assaly, Ragheb; Altorok, Nezam

Beran, Azizullah; Ayesh, Hazem; Mhanna, Mohammed; Srour, Omar; Musallam, Rami; Sayeh, Wasef; Khokher, Waleed; Altorok, Nehaya; Noori, Zaid; Assaly, Ragheb; Altorok, Nezam.

Beran A; Department of Internal Medicine, University of Toledo, Toledo, OH.
Ayesh H; Department of Internal Medicine, University of Toledo, Toledo, OH.
Mhanna M; Department of Internal Medicine, University of Toledo, Toledo, OH.
Srour O; Department of Internal Medicine, University of Toledo, Toledo, OH.
Musallam R; Department of Internal Medicine, St. Vincent Charity Medical Center, Cleveland, OH.
Sayeh W; Department of Internal Medicine, University of Toledo, Toledo, OH.
Khokher W; Department of Internal Medicine, University of Toledo, Toledo, OH.
Altorok N; Department of Internal Medicine, University of Toledo, Toledo, OH.
Noori Z; Division of Pulmonary and Critical Care Medicine, University of Toledo, Toledo, OH.
Assaly R; Department of Internal Medicine, University of Toledo, Toledo, OH.
Altorok N; Division of Pulmonary and Critical Care Medicine, University of Toledo, Toledo, OH.

Am J Ther ; 29(3): e354-e357, 2022.

Article in English | MEDLINE | ID: covidwho-1831519

Subject(s)

COVID-19 Drug Treatment; Methylprednisolone; Dexamethasone/therapeutic use; Glucocorticoids/therapeutic use; Humans; Methylprednisolone/therapeutic use; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Methylprednisolone / COVID-19 Drug Treatment Type of study: Reviews Limits: Humans Language: English Journal: Am J Ther Journal subject: Therapeutics Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google